Comparative Evaluation of Serum Irisin Levels in Cancer Patients and Healthy Individuals: A Systematic Review and Meta-Analysis of Diagnostic Evidence.

IF 1.8 4区 医学 Q3 ONCOLOGY
Rahul Mohandas, Supriya Kheur, Subhashree Mohapatra
{"title":"Comparative Evaluation of Serum Irisin Levels in Cancer Patients and Healthy Individuals: A Systematic Review and Meta-Analysis of Diagnostic Evidence.","authors":"Rahul Mohandas, Supriya Kheur, Subhashree Mohapatra","doi":"10.1080/07357907.2025.2533267","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Irisin influences key cancer-related processes such as cell proliferation, apoptosis, angiogenesis, and metastasis. This review aimed to evaluate serum irisin's potential in cancer diagnosis, prognosis, and treatment monitoring.</p><p><strong>Methods: </strong>Databases including Scopus, PubMed, Cochrane, and others were searched. Studies comparing serum irisin in cancer patients and healthy individuals were assessed using Joanna Briggs Institute criteria.</p><p><strong>Results: </strong>Nine studies showed significantly lower irisin levels in cancer patients (SMD: -1.16, <i>p</i> < 0.0001), especially in hepatocellular and bladder cancers.</p><p><strong>Conclusion: </strong>Reduced serum irisin may serve as a diagnostic cancer biomarker, though its utility varies by cancer type and requires further research.</p><p><strong>Prospero registration no: </strong>CRD420250650210.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"1-17"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07357907.2025.2533267","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Irisin influences key cancer-related processes such as cell proliferation, apoptosis, angiogenesis, and metastasis. This review aimed to evaluate serum irisin's potential in cancer diagnosis, prognosis, and treatment monitoring.

Methods: Databases including Scopus, PubMed, Cochrane, and others were searched. Studies comparing serum irisin in cancer patients and healthy individuals were assessed using Joanna Briggs Institute criteria.

Results: Nine studies showed significantly lower irisin levels in cancer patients (SMD: -1.16, p < 0.0001), especially in hepatocellular and bladder cancers.

Conclusion: Reduced serum irisin may serve as a diagnostic cancer biomarker, though its utility varies by cancer type and requires further research.

Prospero registration no: CRD420250650210.

癌症患者和健康个体血清鸢尾素水平的比较评价:诊断证据的系统回顾和荟萃分析。
背景:鸢尾素影响关键的癌症相关过程,如细胞增殖、凋亡、血管生成和转移。本综述旨在评价血清鸢尾素在癌症诊断、预后和治疗监测方面的潜力。方法:检索Scopus、PubMed、Cochrane等数据库。比较癌症患者和健康个体血清鸢尾素的研究使用乔安娜布里格斯研究所的标准进行评估。结果:9项研究显示,癌症患者血清中鸢尾素水平显著降低(SMD: -1.16, p)。结论:血清中鸢尾素水平降低可能作为诊断癌症的生物标志物,但其效用因癌症类型而异,需要进一步研究。普洛斯彼罗注册号:CRD420250650210。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Investigation
Cancer Investigation 医学-肿瘤学
CiteScore
3.80
自引率
4.20%
发文量
71
审稿时长
8.5 months
期刊介绍: Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信